The U.S. Food and Drug Administration (FDA) has granted approval for Veppanu, a breast cancer medication developed by Pfizer in collaboration with Arvinas. This pill is specifically indicated for patients with advanced stages of breast cancer. The approval marks a significant advancement in treatment options for individuals facing this challenging condition, providing a new therapeutic avenue aimed at improving patient outcomes.
Related Articles
Don't miss out on breaking stories and in-depth articles.